Products
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | 3.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 1.8 | - |
NAV | ₹511.04 | - |
Fund Started | 10 May 2004 | - |
Fund Size | ₹8113.59 Cr | - |
Exit Load | Exit load of 1% if redeemed within 1 month. | - |
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.8
-
NAV
₹511.04
-
Fund Started
10 May 2004
-
Fund Size
₹8113.59 Cr
-
Exit Load
Exit load of 1% if redeemed within 1 month.
-
Returns
1 Year | -0.65% | - |
3 Year | 20.63% | - |
5 Year | 17.65% | - |
1 Year
-0.65%
-
3 Year
20.63%
-
5 Year
17.65%
-
Holding Analysis
Equity | 99.44% | - |
Cash | 0.56% | - |
Equity
99.44%
-
Cash
0.56%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.29% |
Lupin Ltd. | 7.26% |
Divi's Laboratories Ltd. | 7.01% |
Cipla Ltd. | 6.48% |
Apollo Hospitals Enterprise Ltd. | 5.92% |
Dr. Reddy's Laboratories Ltd. | 5.91% |
Vijaya Diagnostic Centre Ltd. | 3.56% |
Medplus Health Services Ltd. | 3.39% |
Gland Pharma Ltd. | 3.24% |
Glaxosmithkline Pharmaceuticals Ltd. | 2.99% |
-
Fund Manager
Name | Akshay Sharma | - |
Start Date | 01 Dec 2022 | - |
Name
Akshay Sharma
-
Start Date
01 Dec 2022
-
About Fund
Description | The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. | - |
Launch Date | 10 May 2004 | - |
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
-
Launch Date
10 May 2004
-